<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for AVNR</title>
    <link />
    <description>Headlines for AVANIR PHARMACEUTICALS</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>July Options Now Available For Avanir Pharmaceuticals (AVNR)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11928551/1/july-options-now-available-for-avanir-pharmaceuticals-avnr.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 20 May 2013 15:19:00 GMT</pubDate>
    </item>
    <item>
      <title>Weekly CEO Sells Highlight: Danaher Corporation, Orbitz Worldwide Inc. ...</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/219464/weekly-ceo-sells-highlight-danaher-corporation-orbitz-worldwide-inc-3d-systems-corporation-and-avanir-pharmaceuticals.aspx?source=itxwebtxt0000015</link>
      <author>GuruFocus</author>
      <pubDate>Mon, 20 May 2013 12:26:30 GMT</pubDate>
    </item>
    <item>
      <title>Weekly CEO Sells Highlight: Danaher Corporation, Orbitz Worldwide Inc. ...</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/weekly-ceo-sells-highlight-danaher-corporation-orbitz-worldwide-inc-cm247228.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 20 May 2013 11:04:08 GMT</pubDate>
    </item>
    <item>
      <title>Avanir Pharmaceuticals' CEO Discusses F2Q13 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1417101-avanir-pharmaceuticals-ceo-discusses-f2q13-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 08 May 2013 22:37:06 GMT</pubDate>
    </item>
    <item>
      <title>Positive CHMP Opinion for Avanir - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98362/positive-chmp-opinion-for-avanir.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 01 May 2013 10:31:01 GMT</pubDate>
    </item>
    <item>
      <title>Stock Upgrades: Disney Turning 'Iron Man' Into Box Office Gold</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/trading-and-investing/stocks/articles/stock-upgrades253a-disney-turning-iron-man/4/29/2013/id/49524.aspx?source=itxwebtxt0000015</link>
      <author>Minyanville</author>
      <pubDate>Mon, 29 Apr 2013 09:23:00 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/27/this-week-in-biotech-24/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 27 Apr 2013 11:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Why Avanir Shares Popped and Then Plunged</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/26/why-avanir-shares-popped-and-then-plunged/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 26 Apr 2013 14:08:00 GMT</pubDate>
    </item>
    <item>
      <title>Pre-Market Most Active for Apr 26, 2013 :  NOK, QQQ, ASML, BAC, MTU, RESI, JCP, BCS, FB, AVNR, ZNGA,</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/premarket-most-active-for-apr-26-2013-nok-qqq-asml-bac-mtu-resi-jcp-bcs-fb-avnr-znga-spnc-cm240993.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 26 Apr 2013 08:39:55 GMT</pubDate>
    </item>
    <item>
      <title>Avanir Pharma Wins Positive CHMP Opinion for Approval of NUEDEXTA in Europe</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3532970/avanir-pharma-wins-positive-chmp-opinion-for-approval-of-nuedexta-in-europe.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 26 Apr 2013 07:45:56 GMT</pubDate>
    </item>
    <item>
      <title>Acorda: A Biotech Company To Consider</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1339031-acorda-a-biotech-company-to-consider.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sat, 13 Apr 2013 09:39:32 GMT</pubDate>
    </item>
    <item>
      <title>Anacor, Gates Foundation Collaborate - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96666/anacor-gates-foundation-collaborate.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 09 Apr 2013 17:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Valeant: The Sole Suitor for Obagi  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96635/valeant-the-sole-suitor-for-obagi.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 09 Apr 2013 14:43:01 GMT</pubDate>
    </item>
    <item>
      <title>Valeant Inks Deal with Actavis  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96540/valeant-inks-deal-with-actavis.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 08 Apr 2013 17:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Pipeline Progresses at Shire  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96428/pipeline-progresses-at-shire.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 05 Apr 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>More Bio-Run Up Ideas</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1318891-more-bio-run-up-ideas.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 03 Apr 2013 16:26:40 GMT</pubDate>
    </item>
    <item>
      <title>ArQule Regains ARQ 092 Rights - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96128/arqule-regains-arq-092-rights.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 02 Apr 2013 17:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Pernix Reports Loss in 4Q  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/95322/pernix-reports-loss-in-4q.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 21 Mar 2013 13:44:01 GMT</pubDate>
    </item>
    <item>
      <title>Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/13/03/3435167/top-4-nasdaq-stocks-in-the-drugs-generic-industry-with-the-highest-cash.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 21 Mar 2013 06:54:32 GMT</pubDate>
    </item>
    <item>
      <title>Data on Eli Lilly's Cialis  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/95152/data-on-eli-lillys-cialis.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 19 Mar 2013 17:52:01 GMT</pubDate>
    </item>
  </channel>
</rss>
